Form D · Other
Dymedso Inc.
Montreal, A8 · CIK 0001828265
Offering snapshot reported Oct 15, 2020 · SEC filing
- Reported sold
- $311K Offering amount: $311K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 28, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 15, 2020 | Initial | $311,147 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-377927
U.S. dollar amounts are based on the Bank of Canada exchange rate reported on September 28, 2020 which was CAD$0.7475 = USD$1.00
10% CVD in the princ. amt of CAD$1,000 maturing on 9/28/ 2022. Each CVD converts at a into Units consisting of 1 cm sh & 1/4 wrt. Each wrt is exer. for 1 cm sh at a conditional price subject to certain terms & conditions.
Source: Form D, filed Oct 15, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kim Anderson | Director, Executive |
| Richard Boudreault | Director, Executive |
| Simon Phaneuf | Director |
| Yvon Robert | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
2120 32 Nd Avenue
Montreal, A8, H8T 3H7
Montreal, A8, H8T 3H7